Crossmark

Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?

Crossref DOI link: https://doi.org/10.15252/emmm.202114781

Published Online: 2021-08-02

Published Print: 2021-08-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Lalli, Giovanna https://orcid.org/0000-0002-5163-640X
Schott, Jonathan M https://orcid.org/0000-0003-2059-024X
Hardy, John https://orcid.org/0000-0002-3122-0423
De Strooper, Bart https://orcid.org/0000-0001-5455-5819
License Information

Version of Record valid from 2021-08-02
More Information

Publication History

Received: 2021-06-28

Accepted: 2021-07-08

Published: 2021-08-02